Fig. 1From: Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathyMean best-corrected visual acuity (BCVA) (logMAR) at baseline and each monthly visit after commencement of intravitreal conbercept for the primary treatment of choroidal neovascularization secondary to punctate inner choroidopathy. Error bar represents standard deviationBack to article page